{
  "data": {
    "indicator": {
      "slug": "ctgov-ibd-trial-starts-s1p",
      "name": "Trial starts since 2023: S1P modulators",
      "definition": "Count of interventional studies naming S1P modulators as an intervention within interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified, started from 2023-01-01 to 2026-09-27.",
      "unit": "count",
      "scale": "1",
      "default_unit": "count",
      "default_scale": "1"
    },
    "scale": "1",
    "unit": "count",
    "region": {
      "code": "GLOBAL",
      "name": "Global",
      "type": "world"
    },
    "points": [
      {
        "period_start": "2023-01-01",
        "period_label": "1 Jan 2023 to 27 Sep 2026",
        "value": 6,
        "scale": "1",
        "unit": "count",
        "value_type": "actual",
        "statistic_id": "stat_7GTRVZ8G79F9ZBNY40KFSZAHN4",
        "url": "https://statorigin.org/stat/stat_7GTRVZ8G79F9ZBNY40KFSZAHN4",
        "source_org": "ClinicalTrials.gov",
        "source": {
          "org": "ClinicalTrials.gov (U.S. National Library of Medicine)",
          "org_short_name": "ClinicalTrials.gov",
          "document_title": "ClinicalTrials.gov study count: Interventional studies of S1P modulators (within: interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified) with a start date from 2023-01-01 to 2026-09-27",
          "document_url": "https://clinicaltrials.gov/api/v2/studies?query.intr=etrasimod%20OR%20ozanimod&query.cond=%22ulcerative%20colitis%22%20OR%20%22Crohn%20disease%22%20OR%20%22Crohn%27s%20disease%22%20OR%20%22inflammatory%20bowel%20disease%22&filter.advanced=AREA%5BStudyType%5DINTERVENTIONAL%20AND%20%28AREA%5BInterventionType%5DDRUG%20OR%20AREA%5BInterventionType%5DBIOLOGICAL%29%20AND%20AREA%5BStartDate%5DRANGE%5B2023-01-01%2C2026-09-27%5D&countTotal=true&pageSize=1&fields=NCTId",
          "locator": "totalCount field of the API response. Query: Interventional studies of S1P modulators (within: interventional drug or biologic studies in ulcerative colitis, Crohn's disease or inflammatory bowel disease not further specified) with a start date from 2023-01-01 to 2026-09-27.",
          "published_date": null
        }
      }
    ],
    "available_regions": [
      "GLOBAL"
    ]
  },
  "meta": {
    "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.",
    "license": "https://creativecommons.org/licenses/by/4.0/",
    "docs": "https://statorigin.org/docs/api",
    "total": 1
  }
}